A 10-year-old boy with poorly controlled asthma on medium-dose inhaled corticosteroid, long-acting beta-agonist, and montelukast has continued severe exacerbations. His total IgE is 1,100 IU/mL, with positive skin tests for multiple inhalant allergens. Which biologic therapy is FDA-approved for this phenotype?